A detailed history of J.Safra Asset Management Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, J.Safra Asset Management Corp holds 1,243 shares of MRK stock, worth $123,616. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,243
Previous 945 31.53%
Holding current value
$123,616
Previous $116,000 21.55%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$111.15 - $128.97 $33,122 - $38,433
298 Added 31.53%
1,243 $141,000
Q2 2024

Jul 17, 2024

BUY
$123.8 - $132.96 $60,538 - $65,017
489 Added 107.24%
945 $116,000
Q1 2024

May 09, 2024

SELL
$113.24 - $131.95 $127,621 - $148,707
-1,127 Reduced 71.19%
456 $60,000
Q4 2023

Feb 02, 2024

SELL
$100.18 - $109.02 $37,868 - $41,209
-378 Reduced 19.28%
1,583 $172,000
Q4 2022

Feb 10, 2023

BUY
$87.44 - $112.11 $171,469 - $219,847
1,961 New
1,961 $217,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track J.Safra Asset Management Corp Portfolio

Follow J.Safra Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.Safra Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on J.Safra Asset Management Corp with notifications on news.